Α-Pyrrolidinopentiothiophenone

From WikiMD's WELLNESSPEDIA

Synthetic stimulant of the cathinone class

α-Pyrrolidinopentiothiophenone (also known as α-PVT) is a synthetic stimulant of the cathinone class. It is chemically related to α-PVP and is known for its stimulant effects. α-PVT has been encountered as a designer drug and is subject to legal restrictions in various jurisdictions.

Chemical structure and properties[edit]

Chemical structure of α-PVT

α-PVT is a thiophene analog of α-PVP, where the phenyl group has been replaced by a thiophene ring. The chemical formula of α-PVT is C14H19NS, and it has a molecular weight of 233.37 g/mol. The presence of the pyrrolidine ring is a characteristic feature of this class of compounds, contributing to its psychoactive properties.

Pharmacology[edit]

α-PVT acts as a norepinephrine-dopamine reuptake inhibitor (NDRI), which means it increases the levels of the neurotransmitters norepinephrine and dopamine in the brain by inhibiting their reuptake into neurons. This action is responsible for its stimulant effects, which can include increased alertness, euphoria, and enhanced cognitive function.

Effects and usage[edit]

The effects of α-PVT are similar to those of other synthetic cathinones, such as increased energy, sociability, and talkativeness. However, it can also cause adverse effects such as anxiety, paranoia, and cardiovascular issues. Due to its potency and potential for abuse, α-PVT is not approved for medical use and is primarily encountered as a recreational drug.

Legal status[edit]

α-PVT in powder form

The legal status of α-PVT varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, α-PVT is listed as a Schedule I substance under the Controlled Substances Act, making it illegal to manufacture, distribute, or possess.

Safety and toxicity[edit]

The safety profile of α-PVT is not well-established, but it is believed to have a high potential for abuse and addiction. Users may experience a range of negative side effects, including increased heart rate, hypertension, and risk of overdose. Long-term use can lead to psychological dependence and other health complications.

Related pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.